{"title": "Local tolerance study of the VA-MENGOC-BC\u00ae antimeningococcal vaccine in Sprague Dawley rats. Evaluation at 24 and 36 months of shelf", "author": "Reynaldo Oliva-Hern\u00c3ndez; Mildrey Fari\u00feas-Medina; Juan F Infante-Bourzac; Tamara Hern\u00c3ndez-Salazar; Darcy N\u00ba\u00feez-Mart\u00danez; Alex Quintero-P\u00d5rez; Concepci\u00b5n Campa-Huergo; Gustavo Sierra-Gonz\u00c3lez", "url": null, "hostname": null, "description": null, "sitename": "VacciMonitor", "date": "2002-01-01", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "2019, Number 1\nVacciMonitor 2019; 28 (1)\nLocal tolerance study of the VA-MENGOC-BC\u00ae antimeningococcal vaccine in Sprague Dawley rats. Evaluation at 24 and 36 months of shelf\n[ ](addFavorito.php?idArt=86452&idPub=8274)\nOliva-Hern\u00c3ndez R, Fari\u00feas-Medina M, Infante-Bourzac JF, Hern\u00c3ndez-Salazar T, N\u00ba\u00feez-Mart\u00danez D, Quintero-P\u00d5rez A, Campa-Huergo C, Sierra-Gonz\u00c3lez G\nLanguage: Spanish\nReferences: 25\nPage: 9-18\nPDF size: 373.09 Kb.\nABSTRACT\nMeningococcal meningitis continues to be a health problem in different countries and different vaccines have been\nobtained for the prevention of this disease. VA-MENGOC-BC\u00db vaccine has been effective and safe in the prevention\nof meningococcal meningitis against serogroups B and C. This has shown good stability over time without changing\nits quality as a product; It was stored on a shelf for 24 and 36 months at temperatures of 4 to 8 \u00a4C. Their possible\ntoxicological potential was evaluated through a local tolerance study in Sprague Dawley rats. Immunized animals were\nobserved daily to evaluate local and systemic toxicity symptoms. Body weight, water and feed intake, thermometry,\nmusculometry were performed and dermal irritability by the Draize method. Anatomopathological studies to observe\npossible adverse effects were made. No symptoms of toxicity or deaths were observed. No differences were found\nbetween the experimental groups in terms of body weight, water and food consumption, no fever or local irritability was\nevident. Anatomopathologically no lesions of diagnostic value were observed, at the site of inoculation, granulomatous\nprocesses of macrophagic type characteristic in vaccines containing aluminum hydroxide were observed. These results\nallowed us to conclude that the VA-MENGOC-BC\u00db vaccine that remained on the shelf for 24 and 36 months did not\nshow any local or systemic effects in rats.\nREFERENCES\nWorld Health Organization. Epidemic meningitis control in countries of the African meningitis belt. The Weekly Epidemiological Record. 2018;93(14):17384. Disponible en: http://www.who.int/wer.\nWorld Health Organization. [Homepage on the internet]. Geneva: Developing a new generation Rapid Diagnostic Tests for Meningitis; 2018. Disponible en: http://www.who.int/emergencies/ diseases/meningitis/en/.\nWorld Health Organization. [Homepage on the internet]. Geneva: Situation Update on Meningitis C Epidemic risk; 2017. Disponible en: http://www.who.int/mediacentre/infographic/meningitis/en/.\nWorld Health Organization. Guidelines on the evaluation of vaccine adjuvants and adjuvanted vaccine, Technical Report Series No 987, Annex 2. Geneva: WHO; 2013. Disponible en: http://www.who. int/biologicals/vaccines/nonclinial_evaluation_of_vaccines/en/.\nWorld Health Organization. Guidelines on nonclinical evaluation of vaccine. Technical Report Series, No. 927. Geneva: WHO; 2005 Disponible en: http://www.who.int/biologicals/vaccines/ nonclinial_evaluation_of_vaccines/en/.\nDraize JH, Woodard G, Calvery HO. Methods for the Study of Irritation and Toxicity of Substances Applied Topically to the Skin and Mucous Membranes. Journal of Pharmacology and Experimental Therapeutics 1944; 3(82):377-90.\nVerdier F. Non-clinical vaccine safety assessment. Toxicology 2002;134(1):37-43.\nOrganization for Economic Cooperation and Development. Guideline for the Testing of Chemicals No 404. Paris: OECD; 2004. Disponible en: http://www.oecd.org/env/testguidelines .\nThe National Academies Press. Guide for the care and use of laboratory animals. Eighth Edition. Washington: NAP; 2010. Disponible en: https://www.nap.edu/download/12910.\nAmerican Veterinary Medical Association. Guidelines on euthanasia. Schaumburg IL: AVMA; 2013. Disponible en: https:// www.avma.org/KB/Policies/Pages/Euthanasia-Guidelines.aspx.\nMorton DB. Humane endpoints in animal experimentation for biomedical research: ethical, legal and practical aspect. Laboratory animals 2005;8:5-12.\nR Development Core Team. R: A language and environment for statistical computing. Vienna: GBIF; 2014. Disponible en: http:// www.R-project.org/.\nN\u00ba\u00feez JF, Herrera L, Infante JF, Gonz\u00c3lez P, P\u00d5rez V, Argamasilla M, et al: Estudio de toxicidad por dosis \u00banica y tolerancia local de una vacuna antimeningoc\u00b5cica tipo B en ratas Sprague Dawley. Vaccimonitor 2006;15(2) 9-14.\nInfante Bourzac JF. Estudio de inocuidad e inmunogenicidad protectog\u00d5nica de la vacuna antimeningoc\u00b5cica VA-MENGOCBC en modelos murinos. [Tesis Doctoral]. La Habana: Universidad Agraria de la Habana; 2000.\nFari\u00feas M, Oliva R, Infante JF, Valdez Y, Nu\u00feez D, Valmaceda T, et al. Ensayo piloto de inmunogenicidad y toxicidad precl\u00danica de la vacuna Salmonella typhi conjugada en ratas Sprague Dawley. Retel. 2014;44:17-34. Disponible en: http://www.sertox.com.ar/ modules.php?name=Content&pa=showpage&pid=936.\nL\u00b5pez Y, Pastor M, Infante JF, D\u00daaz D, Oliva R, Fern\u00c3ndez S, et al. Repeated dose toxicity study of Vibrio cholerae-loaded gastroresistant microparticles. J Microencapsul 2014;31:86-92.\nFari\u00feas M, Arencibia DF, D\u00daas D, Infante JF, Vald\u00d5s Y, Hern\u00c3ndez T, et al. Estudio de Toxicidad por Dosis \u00d6nica de la Vacuna Antimeningoc\u00b5ccica ACW135 en Ratas Sprague Dawley. Retel. 2011;35:23-42. Disponible en: https://www.sertox.com.ar/ modules.php?name=Content&pa=showpage&pid=775.\nCharles River Laboratories. [Homepage on the internet]. Wilmington MA: Charles River Labs-Research Models, Sprague Dawley Rat Informational Resources; 2018. Disponible en: https:// www.criver.com/products-services/find-model/sas-spraguedawley- rat?region=3616.\nTaconic Technical Library. [Homepage on the internet]. Cambridge: Taconic Sprague Dawley, Growth and Phenotyping Data; 2018. Disponible en: http://www.taconic.com/rat-model/ sprague-dawley.\nCanadian Council on Animal Care. Guide to the care and use of experimental animals: Ottawa: CCAC; 1984.\nOchoa RF, Bar\u00b5 IM, Men\u00d5ndez J, Triana T, Mirabal M, Armesto M, et al. Reactogenicidad e inmunogenicidad de una nueva vacuna de toxoide tet\u00c3nico y dift\u00d5rico con concentraci\u00b5n reducida en adolescentes cubanos. VacciMonitor 2006;15(2):13-7.\nGarc\u00daa HM, Thompson R, Valera R, Fando R, Fumane J, Mirabal M, et al. A single dose of live-attenuated 638 Vibrio cholerae oral vaccine is safe and immunogenic in adult volunteers in Mozambique. VacciMonitor 2011;20(3):1-8.\nHexagon. Standard Gage. Precision Measuring Instruments. Estocolmo: Hexagon Metrology; 2018. Disponible en: https:// www.merici-pristroje.cz/files/ckeditor//5_Produkty/Standard_ gage/Standard_Gage.pdf.\nLiguori GR, Jeronimus BF, de Aquinas Liguori TT, Moreira LFP, Harmsen MC. Ethical Issues in the Use of Animal Models for Tissue Engineering: Reflections on Legal Aspects, Moral Theory, Three Rs Strategies, and HarmBenefit Analysis. Tissue Engineering Part C: Methods. 2017;23(12):850-62.\nOrganization for Economic Cooperation and Development. Test No 439, In Vitro Skin Irritation, Reconstructed Human Epidermis Test Method. Paris: OECD; 2015 Disponible en: http://dx.doi. org/10.1787/9789264242845-en.", "language": null, "image": null, "pagetype": null, "links": ["https://www.medigraphic.com/", "resumen.cgi?IDARTICULO=86452", "#", "https://www.medigraphic.com/cgi-bin/new/publicacionesI.cgi?IDREVISTA=268", "https://www.medigraphic.com/cgi-bin/new/contenidoI.cgi?IDPUBLICACION=8274", "https://www.medigraphic.com/cgi-bin/new/publicacionesI.cgi?IDREVISTA=268", "#", "https://www.medigraphic.com/cgi-bin/new/informacion.cgi?IDREVISTA=268", "https://www.medigraphic.com/cgi-bin/new/directorio.cgi?IDREVISTA=268", "#", "https://www.medigraphic.com/cgi-bin/new/instrucciones.cgi?IDREVISTA=268", "https://www.medigraphic.com/", "https://www.medigraphic.com/", "https://www.medigraphic.com/cgi-bin/new/medigraphic.cgi", "#", "#", "#", "#", "addFavorito.php?idArt=86452&idPub=8274", "https://www.medigraphic.com/pdfs/vaccimonitor/vcm-2019/vcm191b.pdf", "#", null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null]}